Fri, 06 Mar | Edgbaston Park Hotel

Bladder Cancer Translational Research Meeting 2020

Bladder Cancer Translational Research Meeting: Novel therapeutics, novel formulations and novel drug delivery
Tickets Are Not on Sale

Time & Location

06 Mar 2020, 09:30 – 16:00
Edgbaston Park Hotel, 53 Edgbaston Park Rd, Birmingham B15 2RS, UK

About the Event


The University of Birmingham and King’s Health Partners are organising their second Bladder Cancer Translational Research Meeting - a fully interactive bladder cancer clinical research meeting led by a wide international expert panel of clinicians and scientists in Birmingham, U.K. The forum is designed to bridge the gap between science and clinical practice and will cover the spectrum of bladder cancer research in oncology, urology, nursing, epidemiology, immuno- and molecular biology. 

Despite the substantial disease burden for patients and healthcare providers, bladder cancer only receives 0.6% of cancer research spending. This meeting will thus provide an opportunity to enhance collaborations across the UK and internationally and allow networking opportunities between clinicians and scientists allowing participants to anticipate crucial observations in the clinical practice to inform research activities and vice versa. Marrying these two diverse disciplines will enable healthcare systems to provide more efficient outcome-driven patient-centred interventions in the field of bladder cancer. 

In addition to engagement through interactive sessions with high impact speakers, we invite participants from their respective units to submit and present their research. Three high impact abstracts will be selected for an oral presentation and the best oral and poster presentations will be awarded with a prize.

The Edgbaston Park Hotel from the University of Birmingham is the venue for this translational research event on 6 March 2020 and we look forward to welcoming delegates to a novel, exciting meeting.

Abstract submission:

Abstracts need to be submitted through XXX (link from Frontiers TBC) by 15 February 2020. Abstracts should be structured (background, methods, results, conclusion) and be no longer than 300 words.  All authors should be listed, including their affiliation. 

Share This Event